Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2017 07:29 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Third Quarter 2017 Financial Results

SAN DIEGO, Nov. 03, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
November 02, 2017 16:06 ET | Source: Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc. and Sono Bello Announce Agreement to Offer Novel Weight Loss Treatment in Sono Bello Centers

SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) and Sono Bello announced today that they had reached an agreement to begin offering the novel Obalon Balloon...
October 26, 2017 08:01 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time

SAN DIEGO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
September 07, 2017 08:58 ET | Source: Obalon Therapeutics, Inc.

Kelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive Team

SAN DIEGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Kelly Huang, Ph.D., has joined as its...
August 02, 2017 07:59 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Second Quarter 2017 Financial Results

SAN DIEGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
July 31, 2017 08:45 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Upcoming Conference Presentation

SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
July 27, 2017 07:50 ET | Source: Obalon Therapeutics, Inc.

Obalon Schedules Second Quarter 2017 Financial Results Conference Call for August 2, 2017 at 8:30 a.m. Eastern Time

SAN DIEGO, July 27, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
May 22, 2017 09:05 ET | Source: Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc. to Present at UBS Global Healthcare Conference

SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
May 11, 2017 08:02 ET | Source: Obalon Therapeutics, Inc.

Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets

SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
May 11, 2017 08:02 ET | Source: Obalon Therapeutics, Inc.

Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets

SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...